| Deler fremragende | 191,698,695 shares |
| Insideraktier | 478.504.883 shares |
| Total Insiders | 42 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Arbutus Biopharma Corporation insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Abrams Michael J. Managing Director - [O] | 42.097 | 42.097 | |
| Daniel D Burgess | 41.000 | ||
| Brennan Paul A. Sr VP, Business Develop - [O] | 38.000 | 38.000 | |
| Herbert J Conrad Director - [D] | 0 | 0 | |
| Andrew Cheng | 22.000 | ||
| Collier William H. President and CEO, Director - [D] [O] | 216.500 | 216.500 | |
| Bruce Cousins | 200.000 | ||
|
Dexxon Holdings Ltd.
10% Owner -
|
32.027.080 | 32.027.080 | |
|
Matthew Gline
Director, 10% Owner -
[D]
|
77.694.924 | 77.694.924 | |
| David C Hastings Chief Financial Officer - [O] | 249.824 | 249.824 | |
| Richard C Jr Henriques Director - [D] | 1.000 | 1.000 | |
| Higgins Patrick T. President & COO - [O] | 3.529.630 | 3.529.630 | |
| Elizabeth Howard EVP, GC, Compliance - [O] | 86.024 | 86.024 | |
| Donald Gordon Jewell Director - [D] | 969.330 | 969.330 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Frank Karbe Director - [D] | 10.000 | 10.000 | |
| Daniel L Kisner Director - [D] | 25.000 | 25.000 | |
| Mark Kowalski | 85.000 | ||
|
Andrew Lo
10% Owner -
|
32.027.080 | 32.027.080 | |
| Peter Lutwyche Chief Tech. Operations Officer - [O] | 77.516 | 77.516 | |
| Keith S Manchester Director - [D] | 46.069 | 46.069 | |
|
Patrick Machado
10% Owner -
|
32.027.080 | 32.027.080 | |
| McElhaugh Michael J. Interim President & CEO, Director - [D] [O] | 1.658.003 | 1.658.003 | |
| James R Meyers | 41.000 | ||
| Murray Mark J. Director - [D] | 341.396 | 341.396 | |
| Naftzger J. Christopher General Counsel and CCO - [O] | 140.544 | 140.544 | |
| Myrtle S Potter | 22.000 | ||
| Peggy V Phillips Director - [D] | 20.000 | 20.000 | |
| Gaston Picchio | 256.500 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
QVT Associates GP LLC
Director, 10% Owner -
[D]
|
32.027.080 | 32.027.080 | |
|
Vivek Ramaswamy
Director, 10% Owner -
[D]
|
32.081.995 | 32.081.995 | |
|
Roivant Sciences Ltd.
10% Owner -
|
38.847.462 | 38.847.462 | |
|
SVF Investments (UK) Ltd
10% Owner -
|
32.027.080 | 32.027.080 | |
| Karen Sims Chief Medical Officer - [O] | 155.494 | 155.494 | |
| Sofia Michael J. Chief Scientific Officer - [O] | 1.485.121 | 1.485.121 | |
|
Sundheim Daniel S.
10% Owner -
|
32.027.080 | 32.027.080 | |
| Symonds William T. Chief Development Officer, Director - [D] [O] | 512.654 | 512.654 | |
| Frank Torti | 41.000 | ||
| Tram Tran | 41.000 | ||
|
Viking Global Investors Lp
10% Owner -
|
32.027.080 | 32.027.080 | |
|
Viking Global Performance Llc
10% Owner -
|
32.027.080 | 32.027.080 | |
| Koert VandenEnden Interim CFO - [O] | 5.500 | 5.500 | |
| Eric Venker | 0 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ABUS / Arbutus Biopharma Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-08-24 | HENRIQUES RICHARD C JR | 1.000 | 6,9500 | 1.000 | 6,9500 | 6.950 | 24 | 7.56 | 610 | 8,78 |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ABUS / Arbutus Biopharma Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 3 | Gline Matthew By Roivant Sciences Ltd. | ABUS | Common Shares | I | 38.847.462 | ||||||||
| 2025-02-19 | 2025-02-14 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 90.100 | 249.824 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 177.000 | 1.658.003 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 54.300 | 140.544 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Sims Karen | ABUS | Common Shares | D | 49.300 | 155.494 | ||||||
| 2025-02-05 | 2025-02-04 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 3,2830 | -11.333 | -37 | 86.244 | ||||
| 2025-02-05 | 2025-02-04 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 3,2830 | -23.790 | -78 | 1.481.003 | ||||
| 2025-02-05 | 2025-02-04 | 4 | Sims Karen | ABUS | Common Shares | D | 3,2830 | -19.348 | -64 | 106.194 | ||||
| 2025-02-05 | 2025-02-04 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 3,2830 | -22.183 | -73 | 159.724 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 3,6895 | -8.846 | -33 | 46.069 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 0,5600 | 54.915 | 31 | 54.915 | ||||
| 2024-02-05 | 2024-02-02 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 2,3125 | -9.593 | -22 | 181.907 | ||||
| 2024-02-05 | 2024-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 112.500 | 191.500 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sims Karen | ABUS | Common Shares | D | 2,3125 | -4.358 | -10 | 125.542 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sims Karen | ABUS | Common Shares | D | 101.000 | 129.900 | ||||||
| 2024-02-05 | 2024-02-01 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 95.100 | 95.100 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 2,3125 | -10.164 | -24 | 1.504.793 | ||||
| 2024-02-05 | 2024-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 123.800 | 1.514.957 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 2,3125 | -9.982 | -23 | 1.485.121 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 109.500 | 1.495.103 | ||||||
| 2023-07-12 | 3 | Sims Karen | ABUS | Common Shares | D | 28.900 | ||||||||
| 2023-02-03 | 2023-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 82.200 | 1.385.603 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 83.700 | 1.391.157 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Collier William H. | ABUS | Common Shares | D | 216.500 | 216.500 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 79.000 | 79.000 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Howard Elizabeth | ABUS | Common Shares | D | 69.700 | 86.024 | ||||||
| 2022-05-26 | 2022-05-25 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Meyers James R | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | BURGESS DANIEL D | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Torti Frank | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41.000 | 41.000 | |||||
| 2022-01-20 | 2022-01-20 | 4 | Picchio Gaston | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 256.500 | 721 | 256.500 | |||
| 2022-01-20 | 2022-01-20 | 4 | Sofia Michael J. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 285.000 | 801 | 285.000 | |||
| 2022-01-20 | 2022-01-20 | 4 | Howard Elizabeth | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 237.500 | 667 | 237.500 | |||
| 2022-01-20 | 2022-01-20 | 4 | HASTINGS DAVID C | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 285.000 | 801 | 285.000 | |||
| 2022-01-20 | 2022-01-20 | 4 | McElhaugh Michael J. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 325.850 | 916 | 325.850 | |||
| 2022-01-20 | 2022-01-20 | 4 | Collier William H. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 787.550 | 2.213 | 787.550 | |||
| 2021-12-03 | 2021-12-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 5,0900 | -200.000 | -1.018 | 1.303.403 | ||||
| 2021-11-12 | 2021-11-09 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 3,50 | 44.000 | 44.000 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Series A participating convertible preferred shares | D | 7,13 | -1.164.000 | 0 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Common shares, without par value | D | 22.833.922 | 38.847.462 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Meyers James R | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Torti Frank | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2,95 | 22.000 | 22.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Picchio Gaston | ABUS | Stock Options | D | 4,33 | 250.000 | 250.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 4,33 | 250.000 | 250.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Collier William H. | ABUS | Stock Options | D | 4,33 | 675.000 | 675.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 4,33 | 200.000 | 200.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 4,33 | 249.000 | 249.000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 4,33 | 290.000 | 290.000 | |||||
| 2021-02-10 | 2021-02-09 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0000 | -20.000 | -100 | 1.307.457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0032 | -10.000 | -50 | 1.327.457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0000 | -30.000 | -150 | 1.337.457 | ||||
| 2020-09-25 | 2020-09-23 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 70.000 | 70.000 | |||||
| 2020-09-25 | 2020-09-23 | 4 | Picchio Gaston | ABUS | Common Stock | D | 3,35 | 50.000 | 50.000 | |||||
| 2020-07-27 | 2020-07-23 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0100 | -20.000 | -100 | 1.367.457 | ||||
| 2020-06-01 | 2020-05-28 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 262.313 | 262.313 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Meyers James R | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Torti Frank | ABUS | Stock Options | D | 2,16 | 22.000 | 22.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 3,35 | 200.000 | 200.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 3,35 | 100.000 | 100.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 367.087 | 367.087 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Picchio Gaston | ABUS | Stock Options | D | 3,35 | 150.000 | 150.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 3,35 | 250.000 | 250.000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 3,35 | 79.500 | 79.500 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Torti Frank | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Meyers James R | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | POTTER MYRTLE S | ABUS | Stock Options | D | 1,50 | 22.000 | 22.000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Cheng Andrew | ABUS | Stock Options | D | 1,50 | 60.000 | 60.000 | |||||
| 2019-06-26 | 2019-06-24 | 4 | Collier William H. | ABUS | Employee Stock Option (Right to Buy) | D | 2,18 | 1.112.000 | 1.112.000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137.500 | 137.500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137.500 | 137.500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 357.500 | 357.500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | McElhaugh Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 104.500 | 104.500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 145.000 | 145.000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Picchio Gaston | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137.500 | 137.500 | |||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2.774.914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2.774.914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2.774.914 | ||||||||
| 2018-12-13 | 2018-12-11 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 4,44 | 7.500 | 7.500 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 1,35 | -25.000 | 0 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Common Shares | D | 1,3500 | 25.000 | 34 | 341.396 | ||||
| 2018-11-27 | 2018-11-26 | 4 | Torti Frank | ABUS | Director Share Option (right to buy) | D | 4,72 | 44.000 | 44.000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | POTTER MYRTLE S | ABUS | Director Share Option (Right to Buy) | D | 4,71 | 44.000 | 44.000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | Meyers James R | ABUS | Director Share Option (Right to Buy) | D | 4,71 | 44.000 | 44.000 | |||||
| 2018-10-10 | 2018-10-08 | 4 | Picchio Gaston | ABUS | Employee Share Option (Right to Buy) | D | 9,38 | 200.000 | 200.000 | |||||
| 2018-08-15 | 2018-08-13 | 4/A | Sofia Michael J. Held by Irrrevocable Trust of Michael J. Sofia dated December 22, 2014 | ABUS | Common Shares | I | 9,5143 | -4.250 | -40 | 167.162 | ||||
| 2018-08-14 | 2018-08-13 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 9,5143 | -4.250 | -40 | 1.499.153 | ||||
| 2018-07-13 | 2018-07-11 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 10,0000 | -10.000 | -100 | 1.503.403 | ||||
| 2018-07-10 | 2018-07-09 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,9060 | -10.000 | -89 | 1.513.403 | ||||
| 2018-07-10 | 2018-07-06 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,4500 | -10.000 | -84 | 1.523.403 | ||||
| 2018-07-06 | 2018-07-05 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,4000 | -10.000 | -84 | 1.533.403 | ||||
| 2018-07-06 | 2018-07-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,0000 | -10.000 | -80 | 1.543.403 | ||||
| 2018-06-25 | 2018-06-19 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | MANCHESTER KEITH S | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | Ramaswamy Vivek | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22.000 | 22.000 | |||||
| 2018-06-21 | 2018-06-19 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 6,75 | 200.000 | 200.000 | |||||
| 2018-04-18 | 2018-04-16 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 160.000 | 160.000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 25.000 | 25.000 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | -27.007 | 0 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Common Shares | D | 0,3540 | 27.007 | 10 | 316.396 | ||||
| 2018-04-17 | 2018-04-16 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 418.187 | 418.187 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 150.000 | 150.000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 30.000 | 30.000 | |||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5.500 | ||||||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5.500 | ||||||||
| 2018-01-16 | 2018-01-12 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Lo Andrew | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Machado Patrick See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7,13 | 100,0000 | 664.000 | 66.400 | 1.164.000 | |||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2017-10-18 | 2017-10-16 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Lo Andrew See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Machado Patrick | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500.000 | 50.000 | 500.000 | |||
| 2017-10-05 | 2017-10-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,0000 | -10.000 | -80 | 1.553.403 | ||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3,6750 | -20.000 | -74 | 171.412 | ||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3,7500 | -10.000 | -38 | 191.412 | ||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2017-06-23 | 2017-06-21 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | Ramaswamy Vivek | ABUS | Stock Option (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22.000 | 22.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 125.000 | 125.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 450.000 | 450.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 150.000 | 150.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 50.000 | 50.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 200.000 | 200.000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 125.000 | 125.000 | |||||
| 2017-03-27 | 2017-03-24 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 3,15 | 50.000 | 50.000 | |||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | 13.503 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | 675 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Common Shares | D | 0,3455 | 14.178 | 5 | 42.097 | ||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Warrants | D | 2,57 | -5.000 | 0 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Common Shares | D | 2,5688 | 5.000 | 13 | 289.389 | ||||
| 2016-06-07 | 2016-06-03 | 4 | KARBE FRANK | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 3,99 | 7.500 | 7.500 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 50.000 | 50.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 145.000 | 145.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Kowalski Mark | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 85.000 | 85.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 60.000 | 60.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 450.000 | 450.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Symonds William T. | ABUS | Executive Stock Option (Right to Buy) | D | 3,94 | 25.000 | 25.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 100.000 | 100.000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 120.000 | 120.000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 35.000 | 35.000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 75.000 | 75.000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 100.000 | 100.000 | |||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77.516 | ||||||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77.516 | ||||||||
| 2015-12-22 | 2015-07-09 | 4 | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 100.000 | 100.000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 75.000 | 75.000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 35.000 | 35.000 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Employee Stock Option (right to buy) | D | 0,44 | -219.428 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Common Shares | D | 0,4444 | 219.428 | 98 | 284.389 | ||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Employee Stock Option (right to buy) | D | 0,44 | -17.044 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Common Shares | D | 0,4444 | 17.044 | 8 | 27.919 | ||||
| 2015-08-26 | 2015-08-24 | 4 | HENRIQUES RICHARD C JR | ABUS | Common Shares | D | 6,9500 | 1.000 | 7 | 1.000 | ||||
| 2015-08-14 | 2015-08-12 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | CONRAD HERBERT J | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7.500 | 7.500 | |||||
| 2015-04-08 | 2015-03-30 | 4 | HENRIQUES RICHARD C JR | TKMR | Stock Option (right to buy) | D | 17,57 | 15.000 | 15.000 | |||||
| 2015-04-07 | 2015-03-30 | 4 | CONRAD HERBERT J | TKMR | Stock Option (right to buy) | D | 17,57 | 15.000 | 15.000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Abrams Michael J. | TKMR | Stock Option (right to buy) | D | 17,57 | 50.000 | 50.000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Cousins Bruce | TKMR | Stock Option (right to buy) | D | 17,57 | 80.000 | 80.000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Murray Mark J. | TKMR | Stock Option (right to buy) | D | 17,57 | 180.000 | 180.000 | |||||
| 2015-03-16 | 3 | CONRAD HERBERT J | TKMR | Common Stock | D | 0 | ||||||||
| 2015-03-16 | 3 | MANCHESTER KEITH S | TKMR | Common Stock, no par value | I | 0 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3.328.218 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1.966.227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1.966.227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3.328.218 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512.654 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512.654 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3.529.630 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3.529.630 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32.081.995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16.123.370 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32.081.995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16.123.370 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32.027.080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32.027.080 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38.000 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38.000 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21.750 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21.750 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129.922 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129.922 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969.330 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969.330 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77.516 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77.516 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20.000 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20.000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10.000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10.000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25.000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25.000 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
